BioAffinity Technologies Inc - Warrants(23/06/2027)
BIAFW
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.8M
Close$
$0.13
40.8% downside
Current Fair Value
40.8% downsideOvervalued by 40.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.80 Million |
|---|---|
| Enterprise Value | $3.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-129.9 |
| Beta | -1.05 |
| Outstanding Shares | 348,450 |
Return
| Return on Equity | -402.92% |
|---|---|
| Return on Assets | -199.30% |
| Return on Invested Capital | -220.05% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | 0.24 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.02 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-2.10
Average shareholder expectationRevenue Estimate
$1.70 M
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-31.50
Average shareholder expectationRevenue Estimate
$1.91 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data